In this second part, RV Radio continues the conversation with four members of the ThinkGenetic Leadership Team to focus the conversation on the day-to-day business and finding investment funding.
The ThinkGenetic leadership team was recently interviewed for the RV Radio podcast with Cian Robinson, discussing the origin of ThinkGenetic while giving insight into what it’s like to be diagnosed with a genetic condition later in life when doctors are stumped and existing tools to diagnose are limited.
Guardian Research Network, Inc.® (GRN) and ThinkGenetic, Inc. announce a strategic collaboration to accelerate the diagnosis and support the development of treatment options for patients with rare and genetic diseases.
ThinkGenetic is proud to announce a recent collaborative research project will be presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) annual meeting this February 25-29th in […]
ThinkGenetic combines modern machine learning with practical information in genetics to solve a major concern in healthcare – the identification of patients living with undiagnosed rare genetic conditions Boston, MA, […]
Horizon Therapeutics plc (Nasdaq: HZNP), in collaboration with MIT Solve, a marketplace for social impact innovation, is proud to announce two winning solutions of this year’s Horizon Prize, ThinkGenetic Inc. and Congenica.
ThinkGenetic, Inc. announces the official acceptance of a $500,000 investment from the Ochsner Lafayette General Healthcare Innovation Fund.
ThinkGenetic, Inc., makers of an artificial intelligence-driven SymptomMatcher™ for genetic disorders, today announced the successful close of its angel round of funding for $1.5M.
Like many other people with a genetic disease, Dave Jacob did not learn that his childhood heart defect was related to an underlying genetic mutation until it was uncovered he […]